Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aixin Li

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Aging Cell|December 9, 2025
A Novel Longitudinal Proteomic Aging Index Predicts Mortality, Multimorbidity, and Frailty in Older AdultsZexi Rao, Shuo Wang, Aixin Li, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2006
Novel 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinaseMark D Wittman, Balu Balasubramanian, Karen Stoffan, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2008
Balancing oral exposure with Cyp3A4 inhibition in benzimidazole-based IGF-IR inhibitorsKurt Zimmermann, Mark D Wittman, Mark G Saulnier, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2010
Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors: SAR of a series of 3-[6-(4-substituted-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridine-2-oneUpender Velaparthi, Mark G Saulnier, Mark D Wittman, et al.
BMC Biology|November 27, 2020
Paxillin mediates ATP-induced activation of P2X7 receptor and NLRP3 inflammasomeWenbiao Wang, Dingwen Hu, Yuqian Feng, et al.
Chinese Medical Journal|January 31, 2023
An open-label evaluation of safety and tolerability of coformulated bictegravir/emtricitabine/tenofovir alafenamide for post-exposure prophylaxis following potential exposure to human immunodeficiency virus-1An Liu, Ruolei Xin, Hongwei Zhang, et al.
Cancer Research|January 2, 2009
The mechanisms of differential sensitivity to an insulin-like growth factor-1 receptor inhibitor (BMS-536924) and rationale for combining with EGFR/HER2 inhibitorsFei Huang, Ann Greer, Warren Hurlburt, et al.
Journal of Cellular and Molecular Medicine|February 12, 2026
Plasma Proteome Signature for Leukocyte Telomere Length and Its Link to Abdominal Aortic AneurysmAixin Li, Thomas R Austin, Brian T Steffen, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2007
Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R)Upender Velaparthi, Mark Wittman, Peiying Liu, et al.
Nano Letters|December 14, 2018
A Biomimetic Nanodecoy Traps Zika Virus To Prevent Viral Infection and Fetal Microcephaly DevelopmentLang Rao, Wenbiao Wang, Qian-Fang Meng, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Aging Cell|December 9, 2025
A Novel Longitudinal Proteomic Aging Index Predicts Mortality, Multimorbidity, and Frailty in Older AdultsZexi Rao, Shuo Wang, Aixin Li, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2006
Novel 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinaseMark D Wittman, Balu Balasubramanian, Karen Stoffan, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2008
Balancing oral exposure with Cyp3A4 inhibition in benzimidazole-based IGF-IR inhibitorsKurt Zimmermann, Mark D Wittman, Mark G Saulnier, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2010
Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors: SAR of a series of 3-[6-(4-substituted-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridine-2-oneUpender Velaparthi, Mark G Saulnier, Mark D Wittman, et al.
BMC Biology|November 27, 2020
Paxillin mediates ATP-induced activation of P2X7 receptor and NLRP3 inflammasomeWenbiao Wang, Dingwen Hu, Yuqian Feng, et al.
Chinese Medical Journal|January 31, 2023
An open-label evaluation of safety and tolerability of coformulated bictegravir/emtricitabine/tenofovir alafenamide for post-exposure prophylaxis following potential exposure to human immunodeficiency virus-1An Liu, Ruolei Xin, Hongwei Zhang, et al.
Cancer Research|January 2, 2009
The mechanisms of differential sensitivity to an insulin-like growth factor-1 receptor inhibitor (BMS-536924) and rationale for combining with EGFR/HER2 inhibitorsFei Huang, Ann Greer, Warren Hurlburt, et al.
Journal of Cellular and Molecular Medicine|February 12, 2026
Plasma Proteome Signature for Leukocyte Telomere Length and Its Link to Abdominal Aortic AneurysmAixin Li, Thomas R Austin, Brian T Steffen, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2007
Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R)Upender Velaparthi, Mark Wittman, Peiying Liu, et al.
Nano Letters|December 14, 2018
A Biomimetic Nanodecoy Traps Zika Virus To Prevent Viral Infection and Fetal Microcephaly DevelopmentLang Rao, Wenbiao Wang, Qian-Fang Meng, et al.
Pageof 10